Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Clinical Study Evaluating the Safety and Performance of the MIST Device for Intraocular Pressure Reduction in Patients With Primary Open-Angle Glaucoma [NA]

View source ↗

Summary

ClinicalTrials.gov reports that the MIST Device is being studied for safety and performance to reduce intraocular pressure in primary open-angle glaucoma, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hexiris Inc | Conditions: Primary Open Angle Glaucoma | NA | Status: RECRUITING